- for infiltration anesthesia apply a 0.5% solution of lidocaine (maximum dose of 400 mg)
- for blockade of peripheral nerves and nerve plexuses 10-20 ml of 1% solution or 5-10 ml of 2% solution (not more than 400 mg).
- for conductive anesthesia apply 1% and 2% solutions (not more than 400 mg).
- for epidural anesthesia 1% and 2% solutions (not more than 300 mg).
- for spinal anesthesia - 3-4 ml of 2% solution (60-80 mg).
- in ophthalmology: 2% solution is instilled in the conjunctival sac by 2 drops 2-3 times at intervals of 30-60 seconds immediately before surgery or examination.
To prolong the action of lidocaine, it is possible to add ex tempore 0.1% of epinephrine solution (1 drop per 5-10 ml of lidocaine solution, but not more than 5 drops for the entire volume of solution).
It is recommended to reduce the dose of lidocaine in elderly patients and patients with liver diseases (cirrhosis, hepatitis) or with reduced hepatic blood flow (chronic heart failure) by 40-50%.
- as an antiarrhythmic drug: intravenously.25 ml of a 10% solution should be diluted with 100 ml of a 0.9% solution of sodium chloride to a lidocaine concentration of 20 mg / ml. This diluted solution is used to administer a loading dose. The introduction begins with a loading dose of 1-1.5 mg / kg (for 2-4 minutes at a rate of 25-50 mg / min) with immediate connection of a constant infusion at a rate of 1-4 mg / min. Due to the rapid distribution (half-life of about 8 minutes), 10-20 minutes after the first dose, the drug concentration in the blood plasma decreases, which may require a repeated bolus administration (against a background of continuous infusion) at a dose of 1 / 2-1 / 3 loading dose, with an interval of 8-10 minutes.
The maximum dose at 1 hour is 300 mg, per day 2000 mg.
Intravenous infusion is usually performed for 12-24 hours with constant ECG monitoring, after which the infusion is discontinued to assess the need for changing antiarrhythmic therapy in the patient.
The rate of excretion of the drug is lowered with heart failure and impaired liver function (cirrhosis, hepatitis), which requires a reduction in the dose and rate of drug administration by 25-50%. With chronic renal failure, dose adjustment is not required.